Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AY7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,147
Award facts
- Contract value 100% obligated
- $44,146.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,146.56 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Opdivo 240 mg/24 mL vials. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Opdivo is a specialty oncology medication used in cancer treatment, reflecting the critical role AmerisourceBergen plays in delivering specialized pharmaceutical commodities to military treatment facilities and federal healthcare systems. The delivery order is scheduled for completion by February 20, 2026, demonstrating the rapid fulfillment capability required for federal medical procurement. AmerisourceBergen's extensive portfolio of federal contracts and substantial IDC vehicle position the company as a primary vendor for the Defense Health Agency and other Department of Defense healthcare programs requiring consistent access to brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1AY7?
SPE2DR26F1AY7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AY7 worth?
The government has obligated $44,147 on SPE2DR26F1AY7.
Is contract SPE2DR26F1AY7 an order under another contract?
Yes. SPE2DR26F1AY7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AY7 competed?
The extent of competition for SPE2DR26F1AY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award